Page 22 - Test PDF v5

« Back to Contents ENDOMETRIAL CANCER

LiFE re

Literature for ENYGO

Treatment of endometrial hyperplasia (biology, conservative
and definitive treatment, follow-up)

Relevant articles retrieved Nov 2015 - Feb 2016

No Title Authors Journal Link to abstract
BJOG.
1 Relapse risk of endometrial hyperplasia after treatment with the levonor- Ørbo A et al. Diagn Interv Imaging. http://www.ncbi.nlm.nih.gov/
gestrel-impregnated intrauterine system or oral pro-gestogens. Pathol Res Pract. pubmed/26630538
Arch Gynecol Obstet.
2 Differentiation between endometrial carcinoma and atypical endometrial Metin MR et al. Am J Obstet Gynecol. http://www.ncbi.nlm.nih.gov/
hyperplasia with transvaginal sonographic elastography. Gynecol Oncol. pubmed/26711550
Anticancer Res.
3 Can Nup88 expression be associated with atypical endometrial hyperplasia Li Y et al. Reprod Sci. http://www.ncbi.nlm.nih.gov/
and endometrial cancer? A preliminary study. Ann Oncol. pubmed/26839161

4 Cyclic versus continuous medroxyprogesterone acetate for treatment of Emarh M. http://www.ncbi.nlm.nih.gov/
endometrial hyperplasia without atypia: a 2-year observational study. pubmed/26015309

5 Obesity and endometrial hyperplasia and cancer in premenopausal women: a Wise M et al. http://www.ncbi.nlm.nih.gov/
systematic review. pubmed/26829507

6 The use of novel technology-based weight loss interventions for obese Haggerty AF et al. http://www.ncbi.nlm.nih.gov/
women with endometrial hyperplasia and cancer. pubmed/26644265

7 Expression of PAX2 and PTEN correlates to therapy response in endometrial Ørbo A et al. http://www.ncbi.nlm.nih.gov/
hyperplasia. pubmed/26637849

8 Depo-provera versus norethisterone acetate in management of endometrial Nooh AM et al. http://www.ncbi.nlm.nih.gov/
hyperplasia without atypia. pubmed/26718306

9 Phase II study of medroxyprogesterone acetate plus metformin as a fertili- Mitsuhashi A et al. http://www.ncbi.nlm.nih.gov/
ty-sparing treatment for atypical endometrial hyperplasia and endometrial pubmed/26578736
cancer.

10 Elastosonographic evaluation of patients with a sonographic finding of Gultekin IB et al. Eur J Obstet Gynecol Reprod http://www.ncbi.nlm.nih.gov/
thickened endometrium. Biol. pubmed/26803388
Obstet Gynecol Sci.
11 Fertility-preserving treatment in complex atypical hyperplasia and early Baek JS et al. http://www.ncbi.nlm.nih.gov/
endometrial cancer in young women with oral progestin: Is it effective? Cochrane Database Syst Rev. pubmed/26866032

12 Levonorgestrel intrauterine system for endometrial protection in women with Dominick S et al. Int J Gynaecol Obstet. http://www.ncbi.nlm.nih.gov/
breast cancer on adjuvant tamoxifen. pubmed/26649916
Cancer Causes Control.
13 Threshold for endometrial sampling among postmenopausal patients without Louie M et al. http://www.ncbi.nlm.nih.gov/
vaginal bleeding. Gynecol Oncol. pubmed/26658096

14 PTEN expression in benign human endometrial tissue and cancer in relation Yang HP et al. http://www.ncbi.nlm.nih.gov/
to endometrial cancer risk factors. pubmed/26376893

15 Effect of oral versus intrauterine progestins on weight in women undergoing Cholakian D et al. http://www.ncbi.nlm.nih.gov/
fertility preserving therapy for complex atypical hyperplasia or endometrial pubmed/26706662
cancer.

16 The accuracy of endometrial sampling in women with postmenopausal van Hanegem N et al. Eur J Obstet Gynecol Reprod http://www.ncbi.nlm.nih.gov/
bleeding: a systematic review and meta-analysis. Biol. pubmed/26748390

17 MR appearance of normal uterine endometrium considering menstrual cycle: Shitano F et al. Acta Radiol. http://www.ncbi.nlm.nih.gov/
differentiation with benign and malignant endometrial lesions. pubmed/26787675

International Journal of Gynecological Cancer, Volume 26, Supplement #1 Page 22